AAAAAA
Results: 1-25/67
Authors:
HADDOW JE
PALOMAKI GE
KNIGHT GJ
FOSTER DL
NEVEUX LM
Citation: Je. Haddow et al., 2ND-TRIMESTER SCREENING FOR DOWNS-SYNDROME USING MATERNAL SERUM DIMERIC INHIBIN-A, Journal of medical screening, 5(3), 1998, pp. 115-119
Authors:
BRADLEY LA
JOHNSON DD
PALOMAKI GE
HADDOW JE
ROBERTSON NH
FERRIE RM
Citation: La. Bradley et al., HEREDITARY HEMOCHROMATOSIS MUTATION FREQUENCIES IN THE GENERAL-POPULATION, Journal of medical screening, 5(1), 1998, pp. 34-36
Authors:
RITCHIE RF
PALOMAKI GE
NEVEUX LM
NAVOLOTSKAIA O
LEDUE TB
CRAIG WY
Citation: Rf. Ritchie et al., REFERENCE DISTRIBUTIONS FOR IMMUNOGLOBULIN-A, IMMUNOGLOBULIN-G, AND IMMUNOGLOBULIN-M - A PRACTICAL, SIMPLE, AND CLINICALLY RELEVANT APPROACH IN A LARGE COHORT, Journal of clinical laboratory analysis, 12(6), 1998, pp. 363-370
Authors:
RITCHIE RF
PALOMAKI GE
NEVEUX LM
NAVOLOTSKAIA O
Citation: Rf. Ritchie et al., REFERENCE DISTRIBUTIONS FOR IMMUNOGLOBULIN-A, IMMUNOGLOBULIN-G, AND IMMUNOGLOBULIN-M - A COMPARISON OF A LARGE COHORT TO THE WORLDS LITERATURE, Journal of clinical laboratory analysis, 12(6), 1998, pp. 371-377
Authors:
KNIGHT GJ
PALOMAKI GE
NEVEUX LM
FODOR KK
HADDOW JE
Citation: Gj. Knight et al., HCG AND THE FREE BETA-SUBUNIT AS SCREENING-TESTS FOR DOWN-SYNDROME, Prenatal diagnosis, 18(3), 1998, pp. 235-245
Authors:
HADDOW JE
PALOMAKI GE
BRADLEY LA
DOHERTY RA
Citation: Je. Haddow et al., SCREENING FOR CYSTIC-FIBROSIS, JAMA, the journal of the American Medical Association, 279(14), 1998, pp. 1068-1068
Authors:
HADDOW JE
PALOMAKI GE
KNIGHT GJ
WILLIAMS J
MILLER WA
JOHNSON A
Citation: Je. Haddow et al., SCREENING OF MATERNAL SERUM FOR FETAL DOWNS-SYNDROME IN THE FIRST-TRIMESTER, The New England journal of medicine, 338(14), 1998, pp. 955-961
Authors:
CRAIG WY
NEVEUX LM
PALOMAKI GE
CLEVELAND MM
HADDOW JE
Citation: Wy. Craig et al., LIPOPROTEIN(A) AS A RISK FACTOR FOR ISCHEMIC-HEART-DISEASE - METAANALYSIS OF PROSPECTIVE STUDIES, Clinical chemistry, 44(11), 1998, pp. 2301-2306
Authors:
COLE LA
KELLNER LH
ISOZAKI T
PALOMAKI GE
ILES RK
WALKER RP
OZAKI M
CANICK JA
Citation: La. Cole et al., COMPARISON OF 12 ASSAYS FOR DETECTING HCG AND RELATED MOLECULES IN URINE SAMPLES FROM DOWN-SYNDROME PREGNANCIES, Prenatal diagnosis, 17(7), 1997, pp. 607-614
Authors:
ISOZAKI T
PALOMAKI GE
BAHADOSINGH RO
COLE LA
Citation: T. Isozaki et al., SCREENING FOR DOWN-SYNDROME PREGNANCY USING BETA-CORE FRAGMENT - PROSPECTIVE-STUDY, Prenatal diagnosis, 17(5), 1997, pp. 407-413
Authors:
STAR J
CANICK JA
PALOMAKI GE
CARPENTER MW
SALLER DN
SUNG CJ
TUMBER MB
COUSTAN DR
Citation: J. Star et al., THE RELATIONSHIP BETWEEN 2ND-TRIMESTER AMNIOTIC-FLUID INSULIN AND GLUCOSE-LEVELS AND SUBSEQUENT GESTATIONAL DIABETES, Prenatal diagnosis, 17(2), 1997, pp. 149-154
Authors:
COLE LA
JACOBS M
ISOZAKI T
PALOMAKI GE
BAHADOSINGH RO
MAHONEY MJ
Citation: La. Cole et al., SCREENING FOR DOWN-SYNDROME USING URINE HCG FREE BETA-SUBUNIT IN THE 2ND-TRIMESTER OF PREGNANCY, Prenatal diagnosis, 17(12), 1997, pp. 1107-1111
Authors:
COLE LA
ACUNA E
ISOZAKI T
PALOMAKI GE
BAHADOSINGH RO
MAHONEY MO
Citation: La. Cole et al., COMBINING BETA-CORE FRAGMENT AND TOTAL ESTRIOL MEASUREMENTS TO TEST FOR DOWN-SYNDROME PREGNANCIES, Prenatal diagnosis, 17(12), 1997, pp. 1125-1133
Authors:
KELLNER LH
CANICK JA
PALOMAKI GE
NEVEUX LM
SALLER DN
WALKER RP
OSATHANONDH R
BOMBARD AT
Citation: Lh. Kellner et al., LEVELS OF URINARY BETA-CORE FRAGMENT, TOTAL ESTRIOL, AND THE RATIO OFTHE 2 IN 2ND-TRIMESTER SCREENING FOR DOWN-SYNDROME, Prenatal diagnosis, 17(12), 1997, pp. 1135-1141
Authors:
PALOMAKI GE
KNIGHT GJ
MCCARTHY JE
HADDOW JE
DONHOWE JM
Citation: Ge. Palomaki et al., MATERNAL SERUM SCREENING FOR DOWN-SYNDROME IN THE UNITED-STATES - A 1995 SURVEY, American journal of obstetrics and gynecology, 176(5), 1997, pp. 1046-1051
Authors:
BRADLEY LA
CANICK JA
PALOMAKI GE
HADDOW JE
Citation: La. Bradley et al., UNDETECTABLE MATERNAL SERUM UNCONJUGATED ESTRIOL LEVELS IN THE 2ND TRIMESTER - RISK OF PERINATAL COMPLICATIONS ASSOCIATED WITH PLACENTAL SULFATASE DEFICIENCY, American journal of obstetrics and gynecology, 176(3), 1997, pp. 531-535
Authors:
PALOMAKI GE
BRADLEY LA
DOHERTY RA
HADDOW JE
Citation: Ge. Palomaki et al., PRENATAL SCREENING FOR CYSTIC-FIBROSIS (CF) - IS IT COST-EFFECTIVE FOR ALL RACIAL ETHNIC GROUPS/, American journal of human genetics, 61(4), 1997, pp. 91-91
Authors:
PALOMAKI GE
NEVEUX LM
KNIGHT GJ
HADDOW JE
Citation: Ge. Palomaki et al., MATERNAL WEIGHT AND FIRST-TRIMESTER DOWN-SYNDROME SCREENING, American journal of human genetics, 61(4), 1997, pp. 915-915
Authors:
PALOMAKI GE
Citation: Ge. Palomaki, DOWNS-SYNDROME EPIDEMIOLOGY AND RISK-ESTIMATION, Early human development, 47, 1996, pp. 19-26
Authors:
DOHERTY RA
PALOMAKI GE
KLOZA EM
ERICKSON JL
HADDOW JE
Citation: Ra. Doherty et al., COUPLE-BASED PRENATAL SCREENING FOR CYSTIC-FIBROSIS IN PRIMARY-CARE SETTINGS, Prenatal diagnosis, 16(5), 1996, pp. 397-404
Authors:
PALOMAKI GE
HADDOW JE
Citation: Ge. Palomaki et Je. Haddow, PRENATAL SERUM MARKERS AND TRISOMY-18, Prenatal diagnosis, 16(5), 1996, pp. 477-478
Authors:
NEVEUX LM
PALOMAKI GE
LARRIVEE DA
KNIGHT GJ
HADDOW JE
Citation: Lm. Neveux et al., REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTS, Prenatal diagnosis, 16(12), 1996, pp. 1115-1119
SIMILARITIES IN WOMENS DECISION-MAKING IN THE US AND UK DURING PRENATAL SCREENING FOR DOWNS-SYNDROME
Authors:
HADDOW JE
PALOMAKI GE
Citation: Je. Haddow et Ge. Palomaki, SIMILARITIES IN WOMENS DECISION-MAKING IN THE US AND UK DURING PRENATAL SCREENING FOR DOWNS-SYNDROME, Prenatal diagnosis, 16(12), 1996, pp. 1161-1162
Authors:
NEVEUX LM
PALOMAKI GE
KNIGHT GJ
HADDOW JE
Citation: Lm. Neveux et al., MULTIPLE MARKER SCREENING FOR DOWN-SYNDROME IN TWIN PREGNANCIES, Prenatal diagnosis, 16(1), 1996, pp. 29-34
Authors:
HADDOW JE
PALOMAKI GE
Citation: Je. Haddow et Ge. Palomaki, DOWNS-SYNDROME SCREENING, Lancet, 347(9015), 1996, pp. 1625-1625